1. Home
  2. APRE vs HIHO Comparison

APRE vs HIHO Comparison

Compare APRE & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • HIHO
  • Stock Information
  • Founded
  • APRE 2006
  • HIHO 1990
  • Country
  • APRE United States
  • HIHO Hong Kong
  • Employees
  • APRE N/A
  • HIHO N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • HIHO Industrial Machinery/Components
  • Sector
  • APRE Health Care
  • HIHO Industrials
  • Exchange
  • APRE Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • APRE 6.9M
  • HIHO 7.7M
  • IPO Year
  • APRE 2019
  • HIHO 1996
  • Fundamental
  • Price
  • APRE $1.16
  • HIHO $1.15
  • Analyst Decision
  • APRE Strong Buy
  • HIHO
  • Analyst Count
  • APRE 1
  • HIHO 0
  • Target Price
  • APRE $20.00
  • HIHO N/A
  • AVG Volume (30 Days)
  • APRE 84.3K
  • HIHO 9.6K
  • Earning Date
  • APRE 11-12-2025
  • HIHO 10-10-2025
  • Dividend Yield
  • APRE N/A
  • HIHO 10.57%
  • EPS Growth
  • APRE N/A
  • HIHO N/A
  • EPS
  • APRE N/A
  • HIHO 0.01
  • Revenue
  • APRE $488,239.00
  • HIHO $7,080,000.00
  • Revenue This Year
  • APRE N/A
  • HIHO N/A
  • Revenue Next Year
  • APRE N/A
  • HIHO N/A
  • P/E Ratio
  • APRE N/A
  • HIHO $120.11
  • Revenue Growth
  • APRE N/A
  • HIHO 3.31
  • 52 Week Low
  • APRE $1.08
  • HIHO $1.12
  • 52 Week High
  • APRE $5.00
  • HIHO $2.05
  • Technical
  • Relative Strength Index (RSI)
  • APRE 37.51
  • HIHO 10.67
  • Support Level
  • APRE $1.08
  • HIHO $1.43
  • Resistance Level
  • APRE $1.28
  • HIHO $1.54
  • Average True Range (ATR)
  • APRE 0.09
  • HIHO 0.05
  • MACD
  • APRE -0.01
  • HIHO -0.03
  • Stochastic Oscillator
  • APRE 30.53
  • HIHO 3.61

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: